- Home
- / Strides Pharma
Strides Pharma
Stock Price
₹1.5 K
2024-10-29
Market Capitalization
₹143.2 B
2024-10-29
Revenue
₹43.9 B
FY, 2025
Strides Pharma Summary
Company Summary
- Overview
- Strides Pharma Science (formerly known as Strides Shasun) is a pharmaceutical company with a focus on the development and manufacture of IP-led niche finished dosage formulations. It is also engaged in the manufacturing of soft gelatin capsules.
- Type
- Public
- Status
- Active
- Founded
- 1990
- HQ
- Bengaluru, IN | view all locations
- Website
- http://www.strides.com/
- Cybersecurity rating
Table of Contents
Key People
S. Sridhar, Independent Director
Bharat Shah, Director
Bharat. D. Shah, Independent Director
LocationsView all
5 locations detected
Bengaluru, KA HQ
India
Krishnaraju Layout, Amalodbhavi Nagar, Panduranga Nagar
East Brunswick, NJ
United States
2 Tower Center Blvd #1102
Lambertville, NJ
United States
201 S Main St #3
Navi Mumbai, MH
India
Devavrata Building, Palm Beach Rd, Sector 17, Vashi
Watford, England
United Kingdom
Unit 4 (side entrance, Metro Centre, Off Dwight Rd, Tolpits Ln
Strides Pharma Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹11.9B
- Gross profit (Q3, 2026)
- ₹8.4B
- Net income (Q3, 2026)
- ₹2.1B
- Cash (Q2, 2026)
- ₹1.4B
- EBIT (Q3, 2026)
- ₹2.9B
- Enterprise value
- $158.7B